INFI Annual Accounts Payable
$4.41 M
+$2.08 M+89.87%
31 December 2022
Summary:
As of January 21, 2025, INFI annual accounts payable is $4.41 million, with the most recent change of +$2.08 million (+89.87%) on December 31, 2022. During the last 3 years, it has risen by +$2.78 million (+171.75%).INFI Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
INFI Quarterly Accounts Payable
$1.50 M
-$433.00 K-22.38%
30 June 2023
Summary:
As of January 21, 2025, INFI quarterly accounts payable is $1.50 million, with the most recent change of -$433.00 thousand (-22.38%) on June 30, 2023. Over the past year, it has dropped by -$311.00 thousand (-17.15%).INFI Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
INFI Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +89.9% | -17.1% |
| 3 y3 years | +171.8% | +16.5% |
| 5 y5 years | +859.7% | +95.8% |
INFI Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | -54.2% | -88.2% |
Infinity Pharmaceuticals Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| June 2023 | - | $1.50 M(-22.4%) |
| Mar 2023 | - | $1.94 M(-56.1%) |
| Dec 2022 | $4.41 M(+89.9%) | $4.41 M(+125.7%) |
| Sept 2022 | - | $1.95 M(+7.7%) |
| June 2022 | - | $1.81 M(-9.5%) |
| Mar 2022 | - | $2.00 M(-13.6%) |
| Dec 2021 | $2.32 M(-22.2%) | $2.32 M(+28.5%) |
| Sept 2021 | - | $1.80 M(+89.2%) |
| June 2021 | - | $954.00 K(-20.8%) |
| Mar 2021 | - | $1.21 M(-59.6%) |
| Dec 2020 | $2.98 M(+84.0%) | $2.98 M(+163.4%) |
| Sept 2020 | - | $1.13 M(-12.2%) |
| June 2020 | - | $1.29 M(-5.3%) |
| Mar 2020 | - | $1.36 M(-16.0%) |
| Dec 2019 | $1.62 M(+35.4%) | $1.62 M(+7.7%) |
| Sept 2019 | - | $1.50 M(+42.8%) |
| June 2019 | - | $1.05 M(-37.4%) |
| Mar 2019 | - | $1.69 M(+40.8%) |
| Dec 2018 | $1.20 M(+160.8%) | $1.20 M(+143.8%) |
| Sept 2018 | - | $491.00 K(-36.0%) |
| June 2018 | - | $767.00 K(+155.7%) |
| Mar 2018 | - | $300.00 K(-34.6%) |
| Dec 2017 | $459.00 K(-81.0%) | $459.00 K(+29.7%) |
| Sept 2017 | - | $354.00 K(-39.1%) |
| June 2017 | - | $581.00 K(-20.7%) |
| Mar 2017 | - | $733.00 K(-69.6%) |
| Dec 2016 | $2.41 M(-74.9%) | $2.41 M(-49.6%) |
| Sept 2016 | - | $4.79 M(-62.4%) |
| June 2016 | - | $12.74 M(+40.1%) |
| Mar 2016 | - | $9.10 M(-5.5%) |
| Dec 2015 | $9.63 M(+61.9%) | $9.63 M(-14.1%) |
| Sept 2015 | - | $11.21 M(+43.2%) |
| June 2015 | - | $7.83 M(+37.4%) |
| Mar 2015 | - | $5.70 M(-4.2%) |
| Dec 2014 | $5.95 M(-6.7%) | $5.95 M(-46.1%) |
| Sept 2014 | - | $11.04 M(+181.4%) |
| June 2014 | - | $3.92 M(-33.0%) |
| Mar 2014 | - | $5.85 M(-8.2%) |
| Dec 2013 | $6.38 M(+196.8%) | $6.38 M(+27.2%) |
| Sept 2013 | - | $5.01 M(+6.6%) |
| June 2013 | - | $4.70 M(+59.9%) |
| Mar 2013 | - | $2.94 M(+36.9%) |
| Dec 2012 | $2.15 M(-63.9%) | $2.15 M(-56.1%) |
| Sept 2012 | - | $4.89 M(-35.7%) |
| June 2012 | - | $7.61 M(+20.2%) |
| Mar 2012 | - | $6.33 M(+6.3%) |
| Dec 2011 | $5.95 M | $5.95 M(+115.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2011 | - | $2.76 M(+9.5%) |
| June 2011 | - | $2.52 M(+12.7%) |
| Mar 2011 | - | $2.24 M(-14.2%) |
| Dec 2010 | $2.61 M(+80.8%) | $2.61 M(+21.2%) |
| Sept 2010 | - | $2.15 M(+32.1%) |
| June 2010 | - | $1.63 M(-36.4%) |
| Mar 2010 | - | $2.56 M(+77.6%) |
| Dec 2009 | $1.44 M(-47.8%) | $1.44 M(-42.2%) |
| Sept 2009 | - | $2.49 M(-36.9%) |
| June 2009 | - | $3.96 M(+38.4%) |
| Mar 2009 | - | $2.86 M(+3.6%) |
| Dec 2008 | $2.76 M(+31.6%) | $2.76 M(-12.9%) |
| Sept 2008 | - | $3.17 M(+50.5%) |
| June 2008 | - | $2.11 M(+11.8%) |
| Mar 2008 | - | $1.88 M(-10.2%) |
| Dec 2007 | $2.10 M(+135.1%) | $2.10 M(+201.8%) |
| Sept 2007 | - | $695.00 K(+8.0%) |
| June 2007 | - | $643.70 K(+41.6%) |
| Mar 2007 | - | $454.70 K(-49.0%) |
| Dec 2006 | $892.20 K(+35.3%) | $892.20 K(-41.5%) |
| Sept 2006 | - | $1.52 M(-8.4%) |
| June 2006 | - | $1.66 M(-38.7%) |
| Mar 2006 | - | $2.72 M(+312.2%) |
| Dec 2005 | $659.30 K(-78.6%) | $659.30 K(-75.9%) |
| Sept 2005 | - | $2.74 M(+6.8%) |
| June 2005 | - | $2.56 M(+35.9%) |
| Mar 2005 | - | $1.89 M(-38.8%) |
| Dec 2004 | $3.08 M(+30.0%) | $3.08 M(+37.7%) |
| Sept 2004 | - | $2.24 M(-14.8%) |
| June 2004 | - | $2.63 M(+20.4%) |
| Mar 2004 | - | $2.18 M(-8.0%) |
| Dec 2003 | $2.37 M(-0.2%) | $2.37 M(-45.4%) |
| Sept 2003 | - | $4.34 M(+13.6%) |
| June 2003 | - | $3.82 M(+28.0%) |
| Mar 2003 | - | $2.99 M(+25.7%) |
| Dec 2002 | $2.38 M(-37.7%) | $2.38 M(-43.2%) |
| Sept 2002 | - | $4.18 M(+26.8%) |
| June 2002 | - | $3.30 M(-7.6%) |
| Mar 2002 | - | $3.57 M(-6.5%) |
| Dec 2001 | $3.82 M(+6.8%) | $3.82 M(+3.9%) |
| Sept 2001 | - | $3.67 M(-1.1%) |
| June 2001 | - | $3.71 M(-16.1%) |
| Mar 2001 | - | $4.43 M(+23.9%) |
| Dec 2000 | $3.57 M(+52.2%) | $3.57 M(-36.0%) |
| Sept 2000 | - | $5.59 M(-6.6%) |
| June 2000 | - | $5.98 M(+194.4%) |
| Mar 2000 | - | $2.03 M |
| Dec 1999 | $2.35 M | - |
FAQ
- What is Infinity Pharmaceuticals annual accounts payable?
- What is the all time high annual accounts payable for Infinity Pharmaceuticals?
- What is Infinity Pharmaceuticals annual accounts payable year-on-year change?
- What is Infinity Pharmaceuticals quarterly accounts payable?
- What is the all time high quarterly accounts payable for Infinity Pharmaceuticals?
- What is Infinity Pharmaceuticals quarterly accounts payable year-on-year change?
What is Infinity Pharmaceuticals annual accounts payable?
The current annual accounts payable of INFI is $4.41 M
What is the all time high annual accounts payable for Infinity Pharmaceuticals?
Infinity Pharmaceuticals all-time high annual accounts payable is $9.63 M
What is Infinity Pharmaceuticals annual accounts payable year-on-year change?
Over the past year, INFI annual accounts payable has changed by +$2.08 M (+89.87%)
What is Infinity Pharmaceuticals quarterly accounts payable?
The current quarterly accounts payable of INFI is $1.50 M
What is the all time high quarterly accounts payable for Infinity Pharmaceuticals?
Infinity Pharmaceuticals all-time high quarterly accounts payable is $12.74 M
What is Infinity Pharmaceuticals quarterly accounts payable year-on-year change?
Over the past year, INFI quarterly accounts payable has changed by -$311.00 K (-17.15%)